SCHEMBL24046764

SCHEMBL24046764

COCOc1cnc(CO)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
DPP4 P27487 1/20 0.38
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
FYN P06241 3/20 0.35
XDH P47989 1/20 0.35
ALDH1A1 P00352 2/20 0.34
NUDT1 P36639 1/20 0.34
P2RX3 P56373 1/20 0.33
P2RX2 Q9UBL9 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6608408 0.95 PDE4A (0.36) PDE4APDE4BPDE4CPDE4DDPP4
SCHEMBL30918494 0.89 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DDPP4
SCHEMBL3930071 0.89 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DDPP4
SCHEMBL15969312 0.81 KCNN4 (0.33) FYNXDHALDH1A1EGFR
SCHEMBL6606565 0.79 ALDH1A1 (0.33) FYNALDH1A1TUBB4ATUBBTUBA3C
SCHEMBL21749946 0.79 S1PR1 (0.44) PDE4APDE4BPDE4CPDE4DDPP4
SCHEMBL24047005 0.79 SMN1; SMN2 (0.36) DPP4XDHALDH1A1P2RX3P2RX2
SCHEMBL6610520 0.77 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DDPP4
SCHEMBL4142722 0.77 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DDPP4
SCHEMBL4148399 0.77 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021236578-A1 CHROMEN-4-ONE DERIVATIVES, SUCH AS E.G. FLAVONES, FOR USE AS CK2 INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATION SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2021-11-25 WO disclosed